Free Newsletter
Sanofi confirms sales rep layoffs
It's been rumored for weeks, and now Sanofi-Aventis is confirming. Yes, the French drugmaker will cut jobs at home in France. Details are sketchy, but here's what we know: Sanofi will lay off 700 to 800 sales reps. That's about one-third of the company's domestic sales force. And the cuts will go deeper than expected; union officials had been bracing themselves for 400 to 600 job losses.
Of course, Sanofi is far from alone in cutting back its sales force this spring. Last month, Merck said it's cutting 1,200 sales reps, and in April, Johnson & Johnson announced 400 cuts in sales and marketing. In March, it was Wyeth saying it would slice 1,200 off the sales payroll.
- see the brief for more
Related Articles:
Ranks of sales reps thinning
Merck to cut 1,200 sales reps
1,200 Wyeth reps out of work
J&J laying off 400 in marketing overhaul
Pfizer to axe 2,200 sales jobs in realignment
Comments
J&J is slashing hundreds of jobs as of June 23rd -
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: